Bain Capital Life Sciences Investors, LLC Mersana Therapeutics, Inc. Transaction History
Bain Capital Life Sciences Investors, LLC
- $298 Million
- Q1 2025
A detailed history of Bain Capital Life Sciences Investors, LLC transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Bain Capital Life Sciences Investors, LLC holds 8,663,673 shares of MRSN stock, worth $3.03 Million. This represents 0.99% of its overall portfolio holdings.
Number of Shares
8,663,673
Previous 8,663,673
-0.0%
Holding current value
$3.03 Million
Previous $12.4 Million
76.23%
% of portfolio
0.99%
Previous 3.35%
Shares
5 transactions
Others Institutions Holding MRSN
# of Institutions
116Shares Held
101MCall Options Held
16.3KPut Options Held
13K-
Nextech Invest, Ltd. Zurich, V812.1MShares$4.22 Million0.97% of portfolio
-
Nextech Invest Ag12.1MShares$4.22 Million3.22% of portfolio
-
Black Rock Inc. New York, NY8.38MShares$2.93 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.38MShares$2.93 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY7.61MShares$2.66 Million0.02% of portfolio
About Mersana Therapeutics, Inc.
- Ticker MRSN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,169,296
- Market Cap $34M
- Description
- Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...